Caption Management, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$8,625,627
-74.6%
327,100
-83.4%
0.13%
-77.9%
Q2 2023$33,947,640
+667.4%
1,973,700
+639.7%
0.60%
+607.1%
Q1 2023$4,423,826
+286.0%
266,817
+132.0%
0.08%
+431.2%
Q3 2022$1,146,000
+0.9%
115,000
-8.0%
0.02%0.0%
Q2 2022$1,136,000
-6.7%
125,000
+4.2%
0.02%
+14.3%
Q1 2022$1,217,000
-96.9%
120,000
-94.9%
0.01%
-96.8%
Q4 2021$39,095,000
+421.3%
2,343,851
+1364.9%
0.44%
+410.5%
Q3 2021$7,499,000
+48.3%
160,000
+92.8%
0.09%
+30.3%
Q2 2021$5,058,000
+24.4%
83,000
+25.8%
0.07%
-24.1%
Q1 2021$4,067,000
+75.9%
66,000
+103.1%
0.09%
+64.2%
Q4 2020$2,312,000
+64.3%
32,500
-13.3%
0.05%
+60.6%
Q3 2020$1,407,000
-79.6%
37,500
-82.3%
0.03%
-85.7%
Q2 2020$6,898,000
+137.9%
211,500
+111.5%
0.23%
+40.2%
Q1 2020$2,900,000100,0000.16%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders